ArticleCurrent medical imaging2025
Clinical Value of Nomogram Model based on Multimodality Ultrasound Image Characteristics Differentiating Benign and Malignant Breast Masses.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFinding a convenient, accurate, and non-invasive method to differentiate between benign and malignant breast masses is especially important for clinical practice, and this study aimed to explore the clinical value of Nomogram model based on multimodality ultrasound image characteristics and clinical baseline data for detecting benign and malignant breast masses.
methodsA retrospective analysis of the clinical data and ultrasound imaging characteristics of 132 patients with breast masses. Data were randomly divided into a training set (92 cases) and a validation set (40 cases) in a ratio of 7:3. Logistic regression was applied to the training set data to analyze risk factors related to malignant breast masses and to construct a Nomogram model. Clinical applicability of the model was evaluated and validated.
resultsIn training set, ROC cure analysis results showed that AUC of Nomogram model constructed with CA15-3, CA125, E DISCUSSION: In this study, we constructed a Nomogram model using risk factors associated with malignant breast masses, and the model showed good clinical applicability in distinguishing benign and malignant breast masses. However, this study is a single-center study, and the sample size of the dataset is relatively small, which, to some extent, limits the breadth and depth of validation.
conclusionThe Nomogram model built on multimodal ultrasound imaging features and clinical data demonstrates a strong discriminative ability for malignant breast masses, allowing patients to achieve a significant net benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.